Friday, January 28, 2022
Advertisement

The Netherlands: Leyden Labs takes US$140m in a Series B financing for new approach...

Amsterdam-based Leyden Laboratories, a biotech company developing products that protect from known and new respiratory viruses, has closed a US$140m Series B financing round...

Australia: Incannex cites poor market conditions for listing in US without raising capital

Incannex Healthcare, the ASX-listed developer of medicinal cannabinoid compounds and psychedelic therapies has shelved plans to raise US$27m from a Nasdaq IPO in favour...

Belgium: Cofinimmo €500m six-year sustainable bond 2.5-times over subscribed

Belgian real-estate investor, Cofinimmo, has placed a benchmark sustainable bond of €500m (US$570m) paying a coupon of 1% per annum, maturing on January 24,...

Norway: Observe Medical’s acquisition values Biim Ultrasound at Nkr185m

Observe Medical, a Nordic-based medtech company focused on developing and commercialising medtech products, has acquired Biim Ultrasound, a Norway-based medical ultrasound technology company, for...

France: Ramsay Santé expands sustainable investor base with €100m ESG-linked private placement bond

Leading European private hospitalisation and primary care provider, Ramsay Santé, has tapped the ESG debt markets once again with its first €100m (US$112.8m) ESG-linked...

Sweden: Medicover issues inaugural social financing Schuldschein raising €277m of private debt

In December 2021, leading international healthcare and diagnostic services company, Sweden-based Medicover, issued a €277m (US$314.2m) private placement debt instrument into the German market...

Hong Kong: Bioheart raises HK$442m from listing on HKEX

Shanghai-based Bioheart is a leading interventional cardiovascular device company, listed shares in December on the Hong Kong stock exchange. It issued a total of...

India: Rainbow Children’s Medicare prepares Rs20bn IPO for 2022

Multi-specialty paediatric, obstetrics and gynaecology hospital chain, Rainbow Children’s Medicare, has filed with SEBI for an IPO for around Rs20bn (US$269m). Proceeds will mainly...

Australia: Bionomics closes US$20m IPO of ADS

Bionomics, an Australia-based clinical-stage biopharmaceutical company, has closed its US IPO of 1.622 million American Depositary Shares (ADS), each representing 180 of the company’s...

Malaysia: Top Glove shareholders approve plans for Hong Kong raise of up to HK$4.24bn

Top Glove has revisited plans to conduct a primary listing on the Hong Kong Stock Exchange, gaining shareholder approval to progress with the idea...